Investor Relations

Celsis International plc is a world leading provider of innovative life science products and laboratory services to the pharmaceutical, biopharmaceutical and consumer products industries.
The company is listed on the London Stock Exchange (CEL.L). Please find more information about Celsis International plc at the links below.

About Celsis Investor Relations
An overview of Celsis International plc and its three divisions; Rapid Detection, Analytical Services and In Vitro Technologies.

Financial Data

Detailed Share Price
Celsis’ current share price and market data information.

Share Price Graph
Historical Celsis share price graph with interactive features.

Financial Reports and Presentations
Celsis’ annual and interim reports available to view and download in pdf format.

Research Notes
Recent research notes about Celsis.

5 Year Summary
A summary of Celsis’ accounts for the last five years.

Financial Calendar
Key Celsis investor dates, including forthcoming preliminary and interim results and Annual General Meeting.

News & Analysis

Letter to Shareholders
An update on Celsis’ performance from Chief Executive, Jay LeCoque and Non-Executive Chairman, Jack Rowell.

Statement of Prospects
A statement from the directors regarding the expected future performance of the Celsis group.

Press Releases
Celsis’ corporate press releases.

People and Contacts

Management Team
Biographical details of Celsis’ Executive and Non-Executive directors.

Analyst & PR
Contact details for Celsis’ company brokers & analyst and public relations agency.

Contact Us
Contact details for Celsis’ internal Investor Relations department, together with the company’s global office details.